Literature DB >> 25415688

Proton beam therapy for the treatment of prostate cancer.

Thomas J Pugh1, Andrew K Lee.   

Abstract

Through unique physical dose deposition properties, proton beam therapy (PBT) potentiates radiation dose escalation to target tissue while minimizing radiation exposure to nontarget organs. Proton beam therapy has been used to treat prostate cancer for several decades; however, access to proton centers has been restricted to the limited number of proton centers. Because of recent enhancements in availability and treatment delivery systems, interest in PBT has been burgeoning among oncologists, industry experts, and prostate cancer patients. As a result, the importance of understanding the collective experience to date and technical aspects of PBT delivery has become increasingly important in cancer medicine. This review article is intended to discuss the fundamentals of PBT treatment, critically review the literature on PBT for localized prostate cancer, and describe the continued development of proton beam technology for the treatment of prostate cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25415688     DOI: 10.1097/PPO.0000000000000083

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  8 in total

Review 1.  Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Authors:  Neha Vapiwala; Charles R Thomas; Surbhi Grover; Mei Ling Yap; Timur Mitin; Lawrence N Shulman; Mary K Gospodarowicz; John Longo; Daniel G Petereit; Ronald D Ennis; James A Hayman; Danielle Rodin; Jeffrey C Buchsbaum; Bhadrasain Vikram; May Abdel-Wahab; Alan H Epstein; Paul Okunieff; Joel Goldwein; Patrick Kupelian; Joanne B Weidhaas; Margaret A Tucker; John D Boice; Clifton David Fuller; Reid F Thompson; Andrew D Trister; Silvia C Formenti; Mary-Helen Barcellos-Hoff; Joshua Jones; Kavita V Dharmarajan; Anthony L Zietman; C Norman Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-05-22       Impact factor: 7.038

2.  The evolution of proton beam therapy: Current and future status.

Authors:  Xiufang Tian; Kun Liu; Yong Hou; Jian Cheng; Jiandong Zhang
Journal:  Mol Clin Oncol       Date:  2017-11-14

3.  Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.

Authors:  Patricia Mae G Santos; Andrew R Barsky; Wei-Ting Hwang; Curtiland Deville; Xingmei Wang; Stefan Both; Justin E Bekelman; John P Christodouleas; Neha Vapiwala
Journal:  Cancer       Date:  2019-09-10       Impact factor: 6.860

4.  Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses.

Authors:  S B Kim; R G Bozeman; A Kaisani; W Kim; L Zhang; J A Richardson; W E Wright; J W Shay
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

5.  Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group.

Authors:  Hiromitsu Iwata; Hitoshi Ishikawa; Masaru Takagi; Tomoaki Okimoto; Sigeyuki Murayama; Tetsuo Akimoto; Hitoshi Wada; Takeshi Arimura; Yoshitaka Sato; Masayuki Araya; Jun-Etsu Mizoe; Masahiko Gosho; Katsumasa Nakamura; Hiroki Shirato; Hideyuki Sakurai
Journal:  Cancer Med       Date:  2018-02-14       Impact factor: 4.452

6.  Tobacco Smoking, Lung Cancer, and Therapy in Iraq: Current Perspective.

Authors:  Buthainah A Ibrahim; Saif Al-Humaish; Mohammed A I Al-Obaide
Journal:  Front Public Health       Date:  2018-10-26

Review 7.  Particle therapy for prostate cancer: The past, present and future.

Authors:  Hitoshi Ishikawa; Hiroshi Tsuji; Shigeyuki Murayama; Mikio Sugimoto; Nobuo Shinohara; Satoru Maruyama; Motohiro Murakami; Hiroki Shirato; Hideyuki Sakurai
Journal:  Int J Urol       Date:  2019-07-08       Impact factor: 3.369

Review 8.  Targeting MicroRNAs in Prostate Cancer Radiotherapy.

Authors:  Jie Ni; Joseph Bucci; Lei Chang; David Malouf; Peter Graham; Yong Li
Journal:  Theranostics       Date:  2017-07-23       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.